Servier

Servier is a top pharmaceutical company based in Suresnes, France

Servier is a top pharmaceutical company based in Suresnes, France.

Servier was founded in 1954, and is the first independent pharmaceutical group in France.

Servier is a global pharmaceutical company that specialises in medication for cardiological and rheumatological conditions, as well as for diabetes and clinical depression.

Report: Partnering Deals and Alliances with Servier

Servier is a top pharmaceutical company based in Suresnes, France.

Servier was founded in 1954, and is the first independent pharmaceutical group in France.

Servier is a global pharmaceutical company that specialises in medication for cardiological and rheumatological conditions, as well as for diabetes and clinical depression.

The company is focused on advancing innovative medicines that provide better options and outcomes, enabling healthier lives.

Servier mainly functions as a research based organisation with its entire activity based on three core principles:

  • To satisfy the needs of the physicians who prescribe its products and patients who benefit from them
  • Innovate research methods and development to contribute to the progress of medicine
  • Fulfilment of all the employees

The SERVIER Clinical Support Unit in Gidy (near Orleans) is the largest unit of its kind in Europe for the production of drugs for clinical trials.

With a strong belief that research is as vital as being and thriving in an industry sector, Servier reinvests 25% of its annual turnover into research and development.

Servier has an active licensing venture investment and acquisition group charged with analysing and managing all incoming opportunities. Servier has a long history of partnering, building numerous collaborative partnerships more

Servier announced over 45 partnering / licensing deals since 2005, of which were 10 signed during the year 2011. Analysis of the partnering deals shows a strong emphasis on partnerships in oncology, CNS disorders, Cardiovascular treatment followed by discover and research tools, diabetes and musculoskeletal difficulties more

Report: Partnering Deals and Alliances with Servier

Examples of recent partnering and licensing deals announced by Servier can be viewed in Current Partnering's Partnering Agreements with Servier 2005-2013 partnering activity review article.

Our report provides more detailed insight into the details of each deal. See Partnering Deals and Alliances with Servier

Available reports from Current Partnering

Report: Partnering Deals and Alliances with Servier

Report: Partnering Deals and Alliances with Big Pharma

Available resources for deal coverage for Servier

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Read: more on Servier company profile, recent partnering, M&A and financing news and articles

Related

Report: Practical Guide to Finding Partners

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk

View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk

Print Friendly, PDF & Email